Metabolic syndrome in the prediction of cardiovascular events: the potential additive role of hsCRP and adiponectin
- 4 April 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 21 (10) , 1242-1248
Abstract
Highly prevalent metabolic syndrome (MS) is a major public health problem worldwide. Insulin resistance and central obesity are postulated to be the key components of this metabolic syndrome, and inflammation also plays a role in cardiovascular events. In previous years, many definitions of metabolic syndrome have emerged. The value of MS as a predictor of cardiovascular events in median 18-year follow-up was studied in a prospective study cohort that included 1004 Finnish males and females. Cardiovascular disease included major coronary heart disease and stroke (excluding subarachnoid hemorrhage)—whichever of these happened first. Subjects with metabolic syndrome had a 2.01-fold (95% CI 1.46–2.77) higher probability for any cardiovascular event compared with subjects with no MS. hsCRP seemed to increase the risk prediction, whereas adiponectin was not helpful. Those having five components of MS had hazard ratios of 7.89 (2.26–27.60) for any cardiovascular event in the follow-up when compared with those having no components and adjusting by traditional risk factors (p < 0.01). MS is an important predictor of cardiovascular events and is most harmful in combination with high plasma hsCRP. The clustering of components is especially harmful.Keywords
This publication has 27 references indexed in Scilit:
- Pre-Diabetes, Metabolic Syndrome, and Cardiovascular RiskJACC, 2012
- Body Fat Measured by a Near‐Infrared Interactance Device as a Predictor of Cardiovascular Events: The FINRISK'92 CohortObesity, 2011
- The Concept of Metabolic Syndrome: Contribution of Visceral Fat Accumulation and Its Molecular MechanismJournal of Atherosclerosis and Thrombosis, 2011
- The Metabolic Syndrome and Cardiovascular RiskJACC, 2010
- C-reactive protein: Risk factor, biomarker and/or therapeutic target?Canadian Journal of Cardiology, 2010
- Harmonizing the Metabolic SyndromeCirculation, 2009
- The Metabolic Syndrome as a Concept of Adipose Tissue DiseaseHypertension Research, 2008
- Low plasma adiponectin concentration is an indicator of the metabolic syndromeEuropean Journal of Endocrinology, 2006
- Should C-Reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk?Circulation, 2004
- Prevalence of the metabolic syndrome in drug‐treated hypertensive patients and control subjectsJournal of Internal Medicine, 1999